Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 11;7(12):e1475873. doi: 10.1080/2162402X.2018.1475873

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Taylor & Francis Group, LLC

PMC Copyright notice

Figure 5. — Expression of immune checkpoint genes across multiple pediatric tumor types. Gene expression of (A) PD-L1, (B) PD-L2, (C) B7-H3, and (D) IDO1 across various pediatric hematologic malignancies (white bars), central nervous system tumors (light gray bars), solid tumors (gray bars), and osteosarcoma (dark gray bar). Statistical significance (p ≤ 0.05) was determined using one-way ANOVA with Holm-Sidak’s multiple comparison test. P values are indicated for each pairwise comparison (vs. osteosarcoma). B-ALL, B-acute lymphoblastic leukemia; T-ALL, T-acute lymphoblastic leukemia; MLL, mixed lineage leukemia; AML, acute myeloid leukemia; LGG, low-grade glioma; EPD, ependymoma; HGG, high-grade glioma; MB, medulloblastoma; CPC, choroid plexus carcinoma; RMS, rhabdomyosarcoma; MEL, melanoma; RB, retinoblastoma; ACT, adrenocortical tumor; OS, osteosarcoma.